Navigation Links
New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
Date:11/10/2011

IPSWICH, Mass., Nov. 10, 2011 /PRNewswire/ -- New England Biolabs (NEB), in its continuing commitment to open access science, announces Polbase, a new, free and open database covering DNA polymerase biochemistry, genetics and structural biology. Inspired by REBASE (the Restriction Enzyme Database, also developed and maintained by NEB), Polbase summarizes the information that exists in the extensive body of polymerase literature, making it easy for researchers to interrogate and use. Polbase can be accessed at http://polbase.neb.com.

(Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b)

Polymerases are responsible for the faithful replication of DNA and maintenance of genomic integrity via repair and recombination. In addition to their biological roles, polymerases with specialized features form the core of many biological techniques, including PCR, and DNA sequencing (Sanger and next generation). This family of enzymes is also finding increased utility in areas of more applied research, such as forensics and diagnostics. Despite their central biological function and growing importance to biotechnology, no single repository of polymerase information existed prior to Polbase.

"Polbase has been designed as a collaborative effort, with contributions from many experts in the various fields of polymerase research," states Dr. Bradley Langhorst, Postdoctoral Fellow at NEB. "We hope that the breadth of information that Polbase provides will enhance research and discovery for polymerase novices and experts alike."

Polbase was funded by a SBIR grant from the NIH (R44GM087021) and builds upon a number of public resources, including PubMed and the Protein Data Bank (PDB), without attempting to duplicate them. Polbase extends current resources with polymerase-centric features that are unavailable elsewhere and presents information in many new and dynamic ways.

About New England Biolabs

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com.


'/>"/>
SOURCE New England Biolabs
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System
2. New England Research Institutes (NERI) Announces Additional $45M NIH Grant to Support the Pediatric Heart Network
3. New England Biolabs and Rubicon Genomics Enter into Distribution Agreement for Single Cell Amplification Products
4. Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy
5. Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products
6. Comprendia and New England Biolabs Connect Epigenetics Scientists with New Social Media Application
7. New England Biolabs Opens New Subsidiary Office in France
8. TEI Biosciences Wins SBANE 2011 New England Innovation Award
9. TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
10. New England Cord Blood Bank: Umbilical Cord Tissue Banking
11. Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of cancer ... breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor ... T cell receptors known as “CARs”. The CAR enables the final product to produce ...
(Date:5/31/2019)... ... 2019 , ... A study released today in STEM CELLS ... sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to treat ... into the injured kidney, where it helped restore function and regenerate injured tissue. ...
(Date:5/15/2019)... ... May 16, 2019 , ... ... a result, food and beverage products rely on these ingredients to create stable ... sounding label declarations. This paradigm shift triggers food formulators to seek out alternatives ...
Breaking Biology Technology:
(Date:6/13/2019)... ... June 13, 2019 , ... ... first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs ... contract and medical research organizations, today announced it will sponsor a summer education ...
(Date:6/6/2019)... ... June 05, 2019 , ... Pelican BioThermal , the ... and service center in Mexico City, Mexico. Mexico is the second largest pharmaceutical ... than $1.75 billion in pharmaceutical exports since 2015. The Mexico City network station ...
(Date:6/4/2019)... ... June 04, 2019 , ... Harper was three years old when ... severe elbow dysplasia, which caused painful osteoarthritis in the joints. She was referred ... were heartbroken. , The surgical specialist, Dr. Christopher Eich of Southern California Veterinary ...
Breaking Biology News(10 mins):